600+ sources. One page. See who else covered it.
Plus news about Avere Therapeutics, Novo Nordisk, Sobi, Innate Pharma, Oculis, Innovent Biologics and Daiichi Sankyo. 🌏 BeOne gets rights to RevMed drugs in 'select Asian markets': The deal includes Revolution Medicines' four clinical RAS ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Gross doesn’t always mean dangerous.
Men living with HIV are transmitting the virus to their female partners at more than three times the rate at which women living with the virus pass it on to men, according to the Ghana AIDS…
Foundayo is made by Eli Lilly, the drug firm behind the Mounjaro jab.
AbCellera’s share price {$ABCL} climbed about 31% by mid-morning Monday after the biotech shared positive data from a mid-stage hot flashes trial that surpassed Wall Street's expectations.
Actio Biosciences, which will receive $820 million up front in the deal, adds to a major upswing in private biotech buyouts seen throughout this year.
Sionna Therapeutics’ bid to become the next cystic fibrosis drug developer after Vertex Pharmaceuticals has taken a major hit, after Sionna reported that its lead asset failed an early study and ...